ArticleDiagnostics (Basel, Switzerland)2026

Characterization and Evaluation of CD24 and NPY as Biomarkers for Metastatic Castration-Resistant Prostate Cancer.

Peter R McHenry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.